Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Breast Cancer|April 13, 2020
Targeting PIK3CA Alterations in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Advanced Breast Cancer: New Therapeutic Approaches and Practical ConsiderationsLee S Schwartzberg, Gregory A Vidal
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast CancerNamratha Vontela, Vamsi Koduri, Lee S Schwartzberg, et al.
The Journal of Biological Chemistry|March 5, 2005
Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activitiesGregory A Vidal, Anjali Naresh, Luis Marrero, et al.
Clinical Breast Cancer|April 8, 2017
Phase I Trial of Everolimus and Capecitabine in Metastatic HER2<sup>-</sup> Breast CancerGregory A Vidal, Mary Chen, Shruti Sheth, et al.
Cancer|May 10, 2022
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancerNadia Harbeck, Harold J Burstein, Sara A Hurvitz, et al.
Clinical Lung Cancer|September 1, 2022
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse EventsMengni Guo, Ari M VanderWalde, Xinhua Yu, et al.
Future Oncology (London, England)|November 10, 2021
Treatment patterns and overall survival in HER2+ metastatic breast cancer at US community oncology practicesGregory A Vidal, Santosh Gautam, Anna Vlahiotis, et al.
Cancer Medicine|October 19, 2022
Mobile application to support oncology patients during treatment on patient outcomes: Evidence from a randomized controlled trialIlana Graetz, Xin Hu, Andrea N Curry, et al.
Cureus|October 5, 2020
Remote Oncology Care: Review of Current Technology and Future DirectionsBradley A McGregor, Gregory A Vidal, Sumit A Shah, et al.
Journal of Cancer Survivorship : Research and Practice|March 2, 2018
Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trialIlana Graetz, Caitlin N McKillop, Edward Stepanski, et al.
Pageof 5